| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2023―Dec―01 |
The role of N-glycosylation in spike antigenicity for the SARS-CoV-2 gamma variant |
Cassandra L Pegg, Naphak Modhiran, Rhys H Parry, Benjamin Liang, Alberto A Amarilla, Alexander A Khromykh, et al. (+5) Lucy Burr, Paul R Young, Keith Chappell, Benjamin L Schulz, Daniel Watterson |
| 2 |
[GO] |
2023―Nov―08 |
Lewis a-b- histo-blood group antigen phenotype is predictive of severe COVID-19 in the black South African population group |
Cliff A Magwira, Ndivho P Nndwamato, Gloria Selabe, Mapaseka L Seheri |
| 3 |
[GO] |
2023―Feb―01 |
Quantitative profiling of N-glycosylation of SARS-CoV-2 spike protein variants |
Yongjing Xie, Michael Butler |
| 4 |
[GO] |
2022―Nov―10 |
Structural remodeling of SARS-CoV-2 spike protein glycans reveals the regulatory roles in receptor binding affinity |
Yen-Pang Hsu, Martin Frank, Debopreeti Mukherjee, Vladimir Shchurik, Alexey Makarov, Benjamin F Mann |
| 5 |
[GO] |
2022―Aug―04 |
Serum N-glycomic profiling may provide potential signatures for surveillance of COVID-19 |
Yongjing Xie, Michael Butler |
| 6 |
[GO] |
2022―Jul―05 |
Inhibition of SARS-CoV-2 wild-type (Wuhan-Hu-1) and Delta (B.1.617.2) strains by marine Sulfated Glycans |
Rohini Dwivedi, Poonam Sharma, Marwa Farrag, Seon Beom Kim, Lauren A Fassero, Ritesh Tandon, Vitor H Pomin |
| 7 |
[GO] |
2020―Sep―24 |
The iminosugars celgosivir, castanospermine and UV-4 inhibit SARS-CoV-2 replication |
Elizabeth C Clarke, Robert A Nofchissey, Chunyan Ye, Steven B Bradfute |
| 8 |
[GO] |
2020―May―02 |
Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 |
Asif Shajahan, Nitin T Supekar, Anne S Gleinich, Parastoo Azadi |
